J. Lewis Research Inc.
Salt Lake City, Utah, United States
Research institute in Salt Lake City, Utah
2295 S, Foothill Dr, Salt Lake City, UT 84109
About J. Lewis Research Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
AstraZeneca
1
BioCryst Pharmaceuticals
1
Eli Lilly and Company
1
GlaxoSmithKline
1
ID Biomedical Corporation, Quebec
1
Lumara Health, Inc.
1
MedImmune LLC
1
Melinta Therapeutics, Inc.
1
ModernaTX, Inc.
1
Novartis Vaccines
1
Clinical Trials at J. Lewis Research Inc.
During the past decade, J. Lewis Research Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
2004-10-01
2005-12-01
Completed
8,500
Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.
2005-09-01
2007-05-01
Unknown status
7,400
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
2007-09-01
2010-07-01
Completed
1,067
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
2008-01-01
2008-02-01
Terminated
82
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
2008-03-01
2009-10-01
Completed
2,907
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
2007-12-01
2008-04-01
Completed
150
Long Term Safety Study of Tanezumab in Chronic Low Back Pain
2009-08-20
2011-06-22
Terminated
849
Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
2004-12-01
2006-11-01
Completed
454
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "J. Lewis Research Inc." #1 sponsor was "Pfizer" with 2 trials, followed by "AstraZeneca" with 1 trials
sponsored, "BioCryst Pharmaceuticals" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "GlaxoSmithKline"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "J. Lewis Research Inc."
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at J. Lewis Research Inc.
According to Clinical.Site data, the most researched conditions in "J. Lewis Research Inc." are
"Influenza" (4 trials), "Abscess" (1 trials), "Acute Treatment of Migraine" (1 trials), "Bacterial Skin Diseases" (1 trials) and "Hot Flashes" (1 trials). Many other conditions were trialed in "J. Lewis Research Inc." in a lesser frequency.
Clinical Trials Intervention Types at J. Lewis Research Inc.
Most popular intervention types in "J. Lewis Research Inc." are "Drug" (9 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ciclesonide nasal aerosol 37 mcg" (1 trials), "Dapagliflozin" (1 trials), "Dapagliflozin placebo" (1 trials) and "Estradiol transdermal one 90 μL spray" (1 trials). Other intervention names were less common.
Clinical Trials Genders at J. Lewis Research Inc.
The vast majority of trials in "J. Lewis Research Inc." are
12 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at J. Lewis Research Inc.
Currently, there are NaN active trials in "J. Lewis Research Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in J. Lewis Research Inc.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in J. Lewis Research Inc., 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".